| Infection Diseases,
| Bacterial Infections,
| Viral Infections (including COVID-19, HIV/AIDS, Monkeypox),
| Fungal Infections,
| Sexually Transmitted Diseases (STDs),
| Communicable Diseases,
| Emerging and Re-emerging Infectious Diseases
| Antimicrobial Resistance and Stewardship
| Vaccine Development and Immunization Programs
| Diagnostic Innovations in Infectious Diseases
| COVID-19 and Lessons for Future Pandemics
| Viral Hepatitis: HBV, HCV, and New Therapies
| HIV/AIDS Research, Prevention, and Treatment
| Vector-Borne Diseases: Malaria, Dengue, Zika
| Tuberculosis: New Strategies in Control and Elimination
| Pediatric Infectious Diseases
| Geriatric Infections and Complications
| Hospital-Acquired and Healthcare-Associated Infections
| Fungal Infections and Invasive Mycoses
| Bacterial Pathogenesis and Host Response
| Infections in Immunocompromised Patients
| Zoonotic Infections and Cross-Species Transmission
| Sexually Transmitted Infections (STIs)
| Global Surveillance and Epidemiological Modeling
| One Health: Human-Animal-Environment Interface
| Infectious Disease in Travel and Migration
| Climate Change and Emerging Infectious Threats
| Microbiome Disruption and Infectious Outcomes
| Precision Medicine and Infectious Diseases
| Antiviral and Antibacterial Drug Discovery
| Infection Control and Public Health Policy
| Biothreats, Bioterrorism, and Emerging Pathogens
| Role of AI in Infectious Disease Management
| Case Studies in Infectious Disease Research and Clinical Practice
| Others
19 to 21 Nov '26
8:00am to 6:00pm (GMT+09:00) Tokyo
Mitsui Garden Hotel Toyosu Premier, Koto City, Toyosu, Tokyo, Japan
